Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: 'Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero' by Satis <i>et al</i>.

Mofors, Johannes; Sonesson, Sven-Erik; Wahren-Herlenius, Marie

Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: 'Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero' by Satis et al.

Mofors, Johannes; Sonesson, Sven-Erik; Wahren-Herlenius, Marie.

Afiliación

Mofors J; Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Sonesson SE; Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hopsital, Stockholm, Sweden.
Wahren-Herlenius M; Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden marie.wahren@ki.se.

Ann Rheum Dis ; 79(8): e95, 2020 08.

Article en En | MEDLINE | ID: mdl-31272943

Asunto(s)

Autoanticuerpos; Hermanos; Anticuerpos Antinucleares; Comorbilidad; Bloqueo Cardíaco/congénito; Humanos

Palabras clave

autoantibodies; autoimmune diseases; cardiovascular disease

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Hermanos Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2020 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google